Henry, N. Lynn http://orcid.org/0000-0002-4771-5930
Kim, Sungjin
Hays, Ron D. http://orcid.org/0000-0001-6697-907X
Diniz, Marcio A.
Tighiouart, Mourad http://orcid.org/0000-0001-8021-5690
Gresham, Gillian
Luu, Michael
Cecchini, Reena S. http://orcid.org/0000-0002-9075-9357
Yothers, Greg http://orcid.org/0000-0002-7965-7333
Rogatko, André
Ganz, Patricia A. http://orcid.org/0000-0002-1841-4143
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1U01CA232859-01, 1U01CA232859-01, 1U01CA232859-01, 1U01CA232859-01, 1U01CA232859-01, 1U01CA232859-01, 1U01CA232859-01, U10CA180868, UG1CA189867, U10CA180822, 1U01CA232859-01)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1 TR001881-01)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 3 May 2022
Accepted: 21 October 2022
First Online: 19 November 2022
Competing interests
: N.L.H. declares the following competing financial interest: payments to her institution for conduct of a pharmaceutical-sponsored clinical trial by Blue Note Therapeutics. P.A.G. declares the following competing financial interest: consulting income from Blue Note Therapeutics, GRAIL, and InformedDNA. The remaining authors declare no competing interests.